Trial Profile
Influence of exceptional patient characteristics on everolimus exposure [De invloed van bijzondere patientkarakteristieken op everolimus blootstelling]
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer
- Focus Pharmacokinetics
- Acronyms INPRES
- 10 Sep 2018 Status changed from recruiting to discontinued.
- 28 Sep 2013 New trial record